Sort
64,565 grants matching “drug discovery”
Office of Cancer Nanotechnology Research
$2,950,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Pharmacogenetics of Membrane Transporters
$2,949,087University Of California San Francisco · U01 · FY2005 · GM
Pre-Clinical and Clinical Evaluation of Skeletal Muscle Activator, CK-2017357 for
$2,948,895Fady Malik · Cytokinetics, Inc. · RC3 · FY2010 · NS
Integrated target discovery in Alzheimer's disease
$2,945,840Christopher David Brown · University Of Pennsylvania · RF1 · FY2017 · AG
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$2,942,076James E. Heubi · University Of Cincinnati · UL1 · FY2009 · RR
JCOIN Phase II Coordination and Translation Center
$2,941,811Faye S Taxman · George Mason University · U2C · FY2025 · DA
Functional Genomics of Bipolar Disorder
$2,941,443Francis J McMahon · National Institute Of Mental Health · ZIA · FY2023 · MH
Metabolic factors that control the spectrum of human tuberculosis
$2,941,042David Branch Moody · Brigham And Women'S Hospital · U19 · FY2020 · AI
Center for Systems Biology
$2,941,030John D. Aitchison · Institute For Systems Biology · P50 · FY2010 · GM
Penn Center for AIDS Research
$2,940,869Ronald G Collman · University Of Pennsylvania · P30 · FY2024 · AI
Genetic Studies of Alzheimer Disease in Koreans
$2,939,748Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2019 · AG
Growth factors, neuroinflammation, exercise, and brain integrity
$2,938,975Paul M Thompson · University Of Southern California · RF1 · FY2014 · AG
Bacterial Determinants of Treatment Response in Mycobacteria Tuberculosis
$2,936,284Megan B Murray · Harvard Medical School · U19 · FY2020 · AI
Cancer Center Support
$2,934,725Nancy E Davidson · University Of Pittsburgh At Pittsburgh · P30 · FY2009 · CA
Autonomic Pharmacodynamic Pharmacogenomics
$2,933,291University Of California San Diego · U01 · FY2003 · HL
Pharmaceutical Research Center
$2,932,203Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2009 · RR
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy
$2,931,750Andrei Thomas-Tikhonenko · Children'S Hosp Of Philadelphia · U01 · FY2018 · CA
Moffitt Cancer Center Support Grant
$2,930,104Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2016 · CA
Moffitt Cancer Center Support Grant
$2,930,104Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2015 · CA
Development of Complement Modulating Therapeutics for AMD
$2,927,483Gregory S Hageman · University Of Iowa · R24 · FY2007 · EY
SPORE IN PROSTATE CANCER
$2,927,204Johns Hopkins University · P50 · FY2001 · CA
Optimization and Development of Non-Hallucinogenic 5-HT2A/2C Agonists as Opioid Use Disorder Therapeutics
$2,923,842Glenn Short III · Atai Therapeutics, Inc. · UG3 · FY2025 · DA
Clinical and biomarker studies in Alzheimer's disease and related disorders
$2,919,364Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2021 · AG
Center for Precision Medicine in Leukemia (CPML)
$2,918,766Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2019 · GM
Informatics, Machine Learning & Biomedical Data Science
$2,918,456Calvin A Johnson · Center For Information Technology · ZIH · FY2019 · CT